Coury Robert J

Mylan, Inc.

Executive Chairman, Director

Avg. Two Year Performance

42% Avg. Purchase Return 19% Compound

(46%) Avg. Sale Return (21%) Compound

Holdings: 0 shares

Last Three Months: 23-Aug-24 -- 22-Nov-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Drugs - Generic

Drugs

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions